OLMA
Companies
NASDAQ
Olema Pharmaceuticals Inc.
Health Care
$4.20
-$1.63 (-27.96%)
Price Chart
Overview
About OLMA
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
Market Cap
$734.4M
Volume
2.3M
Avg. Volume
3.6M
P/E Ratio
-1.9242424
Dividend Yield
0.00%
Employees
78.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.87
Moderate Correlation
Volatility
High (0.78)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Low Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, OLMA shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$734.4M
Volume2.3M
P/E Ratio-1.92
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 14, 2025Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025